More evidence backs insulin glargine safety

The cohort of around 55,000 patients from a US healthcare plan registry, comparing cancer incidence in patients receiving insulin glargine and human NPH, showed a hazard ratio of 1.2 for insulin glargine, indicating no increased risk of cancer.

# Tags